lundi 18 mai 2015

Endo to buy Par for $8B

Son of Valeant, Endo is buying Par Pharmaceutical

http://ift.tt/1Eei4GX

It didn't take Rajiv long to find another acquisition.


Endo to buy Par for $8B

Aucun commentaire:

Enregistrer un commentaire